36.10

0.28% 0.10

After Hours: 36.10

Collegium Pharmaceutical Inc (COLL)

Overview News Price History Option Chain Financials Discussions Forecast

Collegium Pharmaceutical Inc stock is traded at $36.10, with a volume of 411.91K. It is up +0.28% in the last 24 hours and up +4.31% over the past month. Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Previous Close:

$36.00

Open:

$35.89

24h Volume:

411.91K

Relative Volume:

1.03

Market Cap:

$1.14B

Revenue:

$566.77M

Net Income/Loss:

$48.16M

P/E Ratio:

30.34

EPS:

1.19

Net Cash Flow:

$274.29M

1W Performance:

+3.69%

1M Performance:

+4.31%

6M Performance:

+30.56%

1Y Performance:

+7.89%

1-Day Range:

$35.20

$36.58

1-Week Range:

$33.89

$36.58

52-Week Range:

$23.23

$39.95

Collegium Pharmaceutical Inc Stock (COLL) Company Profile

Name

Collegium Pharmaceutical Inc

Sector

Healthcare (1136)

Industry

Drug Manufacturers - Specialty & Generic (85)

Phone

781-713-3699

Address

100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA

Employee

357

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

COLL's Discussions on Twitter

Compare COLL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
COLL Collegium Pharmaceutical Inc	36.10	1.13B	566.77M	48.16M	274.29M	1.19
ZTS Zoetis Inc	144.35	63.86B	9.39B	2.62B	2.22B	5.8121
TAK Takeda Pharmaceutical Co Adr	13.42	42.46B	29.96B	957.25M	4.77B	0.2956
HLN Haleon Plc Adr	9.38	41.28B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	20.52	23.49B	16.70B	-157.13M	1.19B	-0.1446
UTHR United Therapeutics Corp	438.66	19.18B	3.08B	1.24B	1.07B	25.61

Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-10-25	Upgrade	Needham	Hold → Buy
Jul-30-24	Upgrade	H.C. Wainwright	Neutral → Buy
Jun-07-24	Upgrade	Jefferies	Hold → Buy
May-10-24	Downgrade	Needham	Buy → Hold
May-10-24	Downgrade	Piper Sandler	Overweight → Neutral
Jan-04-24	Downgrade	Jefferies	Buy → Hold
Aug-25-23	Reiterated	Needham	Buy
May-02-23	Resumed	Jefferies	Buy
Aug-08-22	Downgrade	H.C. Wainwright	Buy → Neutral
Feb-15-22	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Aug-06-21	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jan-11-21	Reiterated	H.C. Wainwright	Buy
Jul-14-20	Initiated	BWS Financial	Sell
May-27-20	Initiated	Guggenheim	Neutral
Feb-19-20	Resumed	Jefferies	Buy
Oct-30-19	Reiterated	Needham	Buy
May-03-19	Resumed	H.C. Wainwright	Buy
Apr-12-19	Resumed	Janney	Buy
Mar-20-19	Initiated	SunTrust	Hold
Jan-16-19	Reiterated	Needham	Buy
Mar-08-18	Reiterated	H.C. Wainwright	Buy
Feb-07-18	Reiterated	Needham	Buy
Dec-05-17	Reiterated	Needham	Buy
Sep-11-17	Initiated	H.C. Wainwright	Buy
May-11-17	Reiterated	Needham	Buy
Sep-13-16	Initiated	Gabelli & Co	Buy
Jun-01-15	Initiated	Jefferies	Buy
Jun-01-15	Initiated	Needham	Buy
Jun-01-15	Initiated	Piper Jaffray	Overweight

View All

Collegium Pharmaceutical Inc Stock (COLL) Latest News

Nov 03, 2025

Will Collegium Pharmaceutical Inc. (354) stock profit from automation waveQuarterly Portfolio Review & Reliable Intraday Trade Plans - newser.com

Nov 03, 2025

Measuring Collegium Pharmaceutical Inc.’s beta against major indicesWeekly Profit Report & Weekly Consistent Profit Watchlists - newser.com

Nov 03, 2025

Will Collegium Pharmaceutical Inc. stock see PE expansion2025 Top Decliners & Reliable Entry Point Alerts - newser.com

Nov 03, 2025

Can Collegium Pharmaceutical Inc. stock continue upward trendBuy Signal & Daily Chart Pattern Signals - newser.com

Nov 03, 2025

Will Collegium Pharmaceutical Inc. stock keep outperforming rivalsMarket Risk Report & Low Volatility Stock Recommendations - newser.com

Nov 03, 2025

Collegium Pharmaceutical Inc. stock outlook for YEARJuly 2025 Earnings & Expert Verified Movement Alerts - newser.com

Nov 03, 2025

Is Collegium Pharmaceutical Inc. stock reversal real or fakeWeekly Gains Report & Consistent Profit Alerts - newser.com

Nov 03, 2025

How Collegium Pharmaceutical Inc. stock performs during Fed tightening cyclesQuarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com

Nov 03, 2025

Is Collegium Pharmaceutical Inc. stock a top pick in earnings season2025 Big Picture & Precise Entry and Exit Recommendations - newser.com

Nov 03, 2025

Can Collegium Pharmaceutical Inc. (354) stock hit consensus price targetsQuarterly Profit Report & Real-Time Stock Movement Alerts - newser.com

Nov 03, 2025

Is Collegium Pharmaceutical Inc. stock vulnerable to regulatory risksTrade Volume Report & Weekly Market Pulse Updates - newser.com

Nov 03, 2025

Why retail investors pile into Collegium Pharmaceutical Inc. stockEarnings Performance Report & Real-Time Stock Entry Alerts - newser.com

Nov 03, 2025

Will Collegium Pharmaceutical Inc. stock deliver better than expected guidanceEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 03, 2025

Nov 02, 2025

Will Collegium Pharmaceutical Inc. stock gain from strong economyPortfolio Return Report & Low Risk High Reward Trade Ideas - newser.com

Nov 02, 2025

Nov 01, 2025